GB Sciences (GB Sciences) Dividend Yield % : 0.00% (As of May. 04, 2024)

View and export this data going back to 2003. Start your Free Trial

What is GB Sciences Dividend Yield %?

As of today (2024-05-04), the Trailing Annual Dividend Yield of GB Sciences is 0.00%.

The historical rank and industry rank for GB Sciences's Dividend Yield % or its related term are showing as below:

GBLX's Dividend Yield % is not ranked ^*
in the Biotechnology industry.
Industry Median: 1.49
* Ranked among companies with meaningful Dividend Yield % only.

GB Sciences's Dividend Payout Ratio for the three months ended in Dec. 2023 was 0.00.

As of today (2024-05-04), the Forward Dividend Yield % of GB Sciences is 0.00%.

GB Sciences's Dividends per Share for the three months ended in Dec. 2023 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

GB Sciences Dividend Yield % Historical Data

The historical data trend for GB Sciences's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GB Sciences Dividend Yield % Chart

GB Sciences Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Dividend Yield %

Get a 7-Day Free Trial

GB Sciences Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Dividend Yield %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of GB Sciences's Dividend Yield %

For the Biotechnology subindustry, GB Sciences's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

GB Sciences's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GB Sciences's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where GB Sciences's Dividend Yield % falls into.

GB Sciences Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

GB Sciences (OTCPK:GBLX) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

GB Sciences Dividend Yield % Related Terms

Thank you for viewing the detailed overview of GB Sciences's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

GB Sciences (GB Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GB Sciences Inc (OTCPK:GBLX) » Definitions » Dividend Yield %

Comparable Companies

Traded in Other Exchanges

18C:Germany

Address

9205 W. Russell Road, Suite 240, Las vegas, NV, USA, 89148

Website

https://www.gbsciences.com

GB Sciences Inc is active in the healthcare sector. The company is engaged in developing and utilizing technologies in plant biology, cultivation, and extraction techniques combined with biotechnology, and plans to produce medical-grade cannabis, cannabis concentrates, and cannabinoid therapies. It seeks to be a technology and solution company that converts the cannabis plant into medicines, therapies, and treatments for a range of ailments.

Executives

John C Poss	director, officer: Chief Executive Officer
Craig Ellins	director, 10 percent owner, officer: CEO	3035 EAST PATRICK LANE, SUITE 9, LAS VEGAS NV 89120
Lazarus Management Co Llc	10 percent owner	260 N. JOSEPHINE STREET, SUITE 300, DENVER CO 80206
Lazarus Israel Opportunities Fund Lllp	10 percent owner	C/O IBEX GP LLC, 260 NORTH JOSEPHINE STREET, SUITE 300, DENVER CO 80206
Lazarus Investment Partners Lllp	10 percent owner	C/O IBEX INVESTORS LLC, 260 NORTH JOSEPHINE STREET, SUITE 300, DENVER CO 80206
Justin B Borus	10 percent owner	260 N. JOSEPHINE STREET, SUITE 300, DENVER CO 80206